News
All News
Press Releases
Product Approvals and Launches
Video
All Video Types
AJMC TV
Guidelines
Insights
OnLocation
Payer Perspectives
Peer Exchange
Post Conference Perspectives
Stakeholder Summit
Podcasts
Conferences
Conference Coverage
Conference Listing
Post Conference Perspectives
Journals
All Journals
The American Journal of Managed Care
Population Health, Equity & Outcomes
Evidence-Based Oncology
About Supplements and Featured Publications
Supplements and Featured Publications Issues
Submit a Manuscript
Events
Institute for Value-Based Medicine
Patient-Centered Oncology Care
Resources
Interactive Tools
Formulary Central
Clinical Spotlight
Microsites
Sponsored Content
CE
About AJMC
AJMC Staff
Anniversary
Seema Sonnad Award
Strategic Alliance Partners
Subscribe
Specialty Area
Biosimilars
Cardiorenalmetabolic
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Idiopathic Pulmonary Fibrosis
Rheumatology
Women's Health
Topics
Biosimilars
Center on Health Equity & Access
Digital Health
Formulary
Gene Therapy
Guidelines
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Spotlight
Free In-Person Regional Events Focused on Oncology and Population Health
Specialty Area
Biosimilars
Cardiorenalmetabolic
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Idiopathic Pulmonary Fibrosis
Rheumatology
Women's Health
Topics
Biosimilars
Center on Health Equity & Access
Digital Health
Formulary
Gene Therapy
Guidelines
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Spotlight
News
Video
Podcasts
Conferences
Journals
Events
Resources
CE
About AJMC
Subscribe
Advertisement
Lp(a) and Cardiovascular Risk: Advancing Awareness, Testing, and Management in Clinical Practice
: Episode 1
Opinion
Video
December 23, 2024
Lp(a) in ASCVD and Guideline Recommendations
Now Viewing
EP: 1.
Lp(a) in ASCVD and Guideline Recommendations
EP: 2.
Introduction and Burden of Atherosclerotic Disease and Aortic Stenosis
EP: 3.
The Role of Prevention in the Management of Atherosclerotic Disease and Aortic Stenosis
EP: 4.
Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
EP: 5.
Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime
EP: 6.
How the Genetic Nature of Lp(a) Levels Influences Screening
EP: 7.
A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk
EP: 8.
The Role of Management Guidelines in Formulary Decision-Making and Recent Lp(a) Recommendations
EP: 9.
Evidence Supporting 2024 Guidance for Lp(a) Testing
EP: 10.
Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
EP: 11.
Assessing the Quality of Recommendations and Making Clinical Decisions About Lp(a) Testing
EP: 12.
FDA-Approved and Pipeline Treatments for Elevated Lp(a) Levels
EP: 13.
The Benefits of Lp(a) Testing in the Absence of Lp(a)-Lowering Therapies
Related Videos
Related Content
Related Content
